Hyperthermic modulation of resistance to cis-diamminedichloroplatinum(II) in human larynx carcinoma cells

International Journal of Hyperthermia

Volumn 13, Issue 2, 1997, Pages 205-214

  Beketic Oreskovic L ^a   Jaksic M ^a   Oreskovic S ^b   Osmak, M ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cisplatin; Human tumour cells; Hyperthermia; Reversal of drug resistance

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN;

ARTICLE; CELL LINE; DRUG ACCUMULATION; HEATING; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; LARYNX CARCINOMA; TEMPERATURE;

EID: 0030896328     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739709012383     Document Type: Article

References (38)

1. ANDREWS, P. A., 1994, Mechanisms of acquired resistance to cisplatin. In Anticancer Drug Resistance: Advances in Molecular and Clinical Research, edited by R. F. Ozols and L. J. Goldstein (Boston: Kluwer Academic Publishers), pp. 217-248.
2. BEKETIĆ-OREŠKOVIC, L., and OSMAK, M., 1994, Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): Cross resistance patterns. Neoplasma, 41, 171-176.
3. BEKETIĆ-OREŠKOVIĆ, L., OSMAK, M., JAKŠIĆ, M., 1994, Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance. Neoplasma, 41, 163-169.
4. BEKETIĆ-OREŠKOVIĆ, L., and OSMAK, M., 1995, Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells. Cancer Chemotherapy Pharmacology, 35, 327-333.
5. CALSOU, P., and SALLES., B., 1993, Role of DNA repair in the mechanisms of cells resistance to alkylating agents and cisplatin. Cancer Chemotherapy Pharmacology, 32, 85-89.
6. EICHOLTZ-WIRTH. H., and HIETEL, B., 1990, Heat sensitization to cisplatin in two cell lines with different drug sensitivities. International Journal of Hyperthermia, 6, 47-55.
7. ENGIN, K., 1994a, Biological rationale for hyperthermia in cancer treatment (II). Neoplasma, 41, 277-283.
8. ENGIN, K., 1994b, Hyperthermia in cancer treatment (I). Neoplasma, 41, 269-276.
9. EPELBAUM, R., TEICHER, B., HOLDEN, S. A., ARA, G., VARSHNEY, A., and HERMAN, T. S., 1992, Interaction of D, L- and D- tetraplatin with hyperthermia in vitro and in vivo. European Journal of Cancer, 28, 794-800.
10. FREEMAN, M. L., MEREDITH, M. J., and EISERT, D. R., 1990, Failure of chronic glutathione elevation to reduce cytotoxicity produced by exposure to cis-diamminedichloroplatinum(II), ionizing radiation, or hyperthermia. Cancer Research, 50, 5296-5300.
11. GATELY, D. P., and HOWELL, S. B., 1993, Cellular accumulation of the anticancer agent cisplatin. A review. British Journal of Cancer, 67, 1171-1176.
12. 2 (tetrachloroplatinum(II)) in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline. Cancer Research, 48, 5101-5105.
13. HETTINGA, J. V. E., LEMSTRA, W., MEIJER, C., MULDER, N. H., KONINGS, A. W. T., DEVRIES, E. G. E., and KAMPINGA, H. H., 1994, Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant subline. International Journal of Hyperthermia, 10, 795-805.
14. HETTINGA, J. V. E., LEMSTRA, W., DEVRIES, E. G. E., KONINGS, A. W. T., and KAMPINGA, H. H., 1995, Sensitization to cisplatin action by step-down heating in CDDP-sensitive and -resistant cells. International Journal of Cancer, 61, 722-726.
15. ISSELS, R. D., 1996, Clinical rationale for thermochemotherapy. In Thermoradiotherapy and thermochemotherapy, edited by M. H. Seegenschmiedt, P. Fessenden and C. C. Vernon (New York: Springer), pp. 25-33.
16. KIMURA, E., and HOWELL, S. B., 1993, Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line. Cancer Chemotherapy Pharmacology, 32, 419-24.
17. KONINGS, A. W. T., HETTINGA, J. V. E., LEMSTRA, W., HUMPHREY, G. B., and KAMPINGA, H. H., 1993, Sensitizing for cis-diamminedichloro-platinum(II) action by hyperthermia in resistant cells. International Journal of Hyperthermia, 9, 553-562.
18. LEŠNIČAR, H., and BUDIHNA, M., 1992, Potentials of hyperthermia in clinical use. Advanced Radiology and Oncology, pp. 284-298.
19. MALMQUIST, K. G., 1988, Quantitative PIXE analysis of biomedical material-sample preparation, irradiation and quality control. In Particle induced X-ray emission and its analytical applications, edited by R. D. Vis (Amsterdam: North Holland), pp. 183-190.
20. MANSOURI, A., HENLE, K. J., BENSON, A. M., MOSS, A. J., and NAGLE, W. A., 1989, Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia. Cancer Research, 49, 2674-2678.
21. MITCHELL, J. B., COOK, J., DEGRAAF, W., GLATSTEIN, E., and RUSSO, A., 1989, Glutathione modulation in cancer treatment: will it work? (Keynote address). International Journal of Radiation Oncology, Biology and Physics, 16, 1289-1295.
22. NAKATA, B., BARTON, R. M., ROBBINS, K. T., HOWELL, S. B., and Loss, G., 1994, Association between hsp60 mRNA levels and cisplatin resistance in human head and neck cancer cell lines. Oncology, 5, 1425-1432.
23. NEILAN, B. A., HENLE, K. J., NAGLE, W. A., and MOSS, A. J., 1986, Cytotoxicity of hyperthermia combined with Bleomycin or cis-Platinum in cultured RIF cells: modification by thermotholerance and by polyhydroxy compounds. Cancer Research, 46, 2245-2251.
24. OSMAK, M., 1992, Collateral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis-diamminedichloro-platinum(II) or vincristine sulfate. Neoplasma, 39, 197-202.
25. OSMAK, M., BEKETIĆ-OREŠKOVIC, L., MATULIĆ, M., and SORIĆ, J., 1993, Resistance of human larynx carcinoma cells to cisplatin, gamma irradiation and methotrexate do not involve overexpression of c-myc or c-Ki-ras oncogenes. Mutation Research, 303, 113-120.
26. OVERGAARD, J., and HORSMAN, M. R., 1993, Hyperthermia. In Basic clinical radiobiology, edited by G. Gordon Steel (London: Edward Arnold), pp. 173-184.
27. RAAPHORST, G. P., CHABOT, P., DOJA, S., WILKINS, D., STEWART, D., and NG, C. E., 1996a, Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment. International Journal of Hyperthermia, 129, 211-222.
28. RAAPHORST, G. P., DOJA, S., DAVIS, L., STEWART, D., and NG, C. E., 1996b. A comparison of hyperthermia cisplatin sensitisation in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemotherapy and Pharmacology, 37, 574-580.
29. RAAPHORST, G. P., YANG, D. P., GREWAAL, D., GOEL, R., and NG, C. E., 1995, Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncology Reports, 2, 1037-1043.
30. SCANLON, K. J., KASHANI-SABET, M., TONE, T., and FUNATO, T., 1991, Cisplatin resistance in human cancers. Pharmacology Therapy, 52, 385-406.
31. SHCHEPOTIN, I. B., SHABAHANG, M., NAUTA, R. J., BURAS, R. R., BRENNER, R. V., and EVANS, S. R. T., 1994, Antitumor activity of 5-fluorouracil, verapamil and hyperthermia against human gastric adenocarcinoma cell (AGS) in vitro. Surgical Oncology, 3, 287-294.
32. STEWART, D. J., and EVANS, W. K., 1989, Non-chemotherapeutic agents that potentiate chemotherapy efficacy. Cancer Treatment Review, 16, 1-40.
33. TIMMER-BOSCHA, H., MULDER, N. H., and DE VRIES. E. G. E., 1992, Modulation of cis-diamminedichloroplatinum(II) resistance: a review. British Journal of Cancer, 66, 227-233.
34. URANO, M., BEGLY, J., and REYNOLDS, R., 1994, Interaction between adriamycin cytotoxicity and hyperthermia: growth-phase-dependent thermal sensitization. International Journal of Hyperthermia, 10, 817-826.
35. VERNON, C., 1992, Hyperthermia in cancer growth regulation. Biotherapy, 4, 307-315.
36. WALLNER, K. E., DE GREGORIO, M. W., and LI, G. C., 1986, Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese Hamster Ovary cells resistant to the drug. Cancer Research, 46, 6242-6245.
37. WAXMAN, D. J., 1990, Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy - a review. Cancer Research, 50, 6449-6454.
38. YANO, T., NAKATANI, K., WATANABE, A., NAKANO, H., and OHNISHI, T., 1993, Effects of preheating on cis-diamminedichloro-platinum(II)-hyperthermia-induced tumour growth depression of transplantable human oesophageal cancer to nude mice. International Journal of Hyperthermia, 9, 699-708.